相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Remission or low disease activity as a target in systemic lupus erythematosus
Manuel Francisco Ugarte-Gil et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Prolonged remission is associated with a reduced risk of cardiovascular disease in patients with systemic lupus erythematosus: a GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study
Serena Fasano et al.
CLINICAL RHEUMATOLOGY (2019)
2019 update of the EULAR recommendations for the management of systemic lupus erythematosus
Antonis Fanouriakis et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Clinical Remission and Low Disease Activity Outcomes Over 10 Years in Systemic Lupus Erythematosus
Konstantinos Tselios et al.
ARTHRITIS CARE & RESEARCH (2019)
Disease course patterns in systemic lupus erythematosus
K. Tselios et al.
LUPUS (2019)
New therapeutic strategies in systemic lupus erythematosus management
Mariele Gatto et al.
NATURE REVIEWS RHEUMATOLOGY (2019)
Predictive factors of flares in systemic lupus erythematosus patients: data from a multiethnic Latin American cohort
M. F. Ugarte-Gil et al.
LUPUS (2018)
The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults
Caroline Gordon et al.
RHEUMATOLOGY (2018)
Adherence to hydroxychloroquine improves long-term survival of patients with systemic lupus erythematosus
Chung-Yuan Hsu et al.
RHEUMATOLOGY (2018)
Comparison of Remission and Lupus Low Disease Activity State in Damage Prevention in a United States Systemic Lupus Erythematosus Cohort
Michelle Petri et al.
ARTHRITIS & RHEUMATOLOGY (2018)
First Latin American clinical practice guidelines for the treatment of systemic lupus erythematosus: Latin American Group for the Study of Lupus (GLADEL, Grupo Latino Americano de Estudio del Lupus)-Pan-American League of Associations of Rheumatology (PANLAR)
Bernardo A. Pons-Estel et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Mortality and prognostic factors in Chinese patients with systemic lupus erythematosus
L. Mu et al.
LUPUS (2018)
Lupus low disease activity state is associated with a decrease in damage progression in Caucasian patients with SLE, but overlaps with remission
Margherita Zen et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
The effect of different durations of remission on damage accrual: results from a prospective monocentric cohort of Caucasian patients
Margherita Zen et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS)
Ronald van Vollenhoven et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Both prolonged remission and Lupus Low Disease Activity State are associated with reduced damage accrual in systemic lupus erythematosus
Michel W. P. Tsang-A-Sjoe et al.
RHEUMATOLOGY (2017)
Clinicians approaches to management of background treatment in patients with SLE in clinical remission: results of an international observational survey
Pintip Ngamjanyaporn et al.
LUPUS SCIENCE & MEDICINE (2017)
Prevalence of remission and its effect on damage and quality of life in Chinese patients with systemic lupus erythematosus
Chi Chiu Mok et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
From old concerns to new advances and personalized medicine in lupus: The end of the tunnel is approaching
Andrea Doria et al.
JOURNAL OF AUTOIMMUNITY (2016)
Prolonged remission in Caucasian patients with SLE: prevalence and outcomes
Margherita Zen et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Value and goals of treat-to-target in systemic lupus erythematosus: knowledge and foresight
A. Doria et al.
LUPUS (2015)
The number of flares patients experience impacts on damage accrual in systemic lupus erythematosus: data from a multiethnic Latin American cohort
Manuel F. Ugarte-Gil et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
The clinically quiescent phase in early-diagnosed SLE patients: inception cohort study
Nuntana Kasitanon et al.
RHEUMATOLOGY (2015)
Optimizing outcome in SLE: treating-to-target and definition of treatment goals
Andrea Doria et al.
AUTOIMMUNITY REVIEWS (2014)
Identification of clinical predictors of flare in systemic lupus erythematosus patients: a 24-month prospective cohort study
Luis Ines et al.
RHEUMATOLOGY (2014)
How should lupus flares be measured? Deconstruction of the Safety of Estrogen in Lupus Erythematosus National Assessment-Systemic Lupus Erythematosus Disease Activity Index flare index
Aikaterini Thanou et al.
RHEUMATOLOGY (2014)
Hydroxychloroquine in systemic lupus erythematosus: results of a French multicentre controlled trial (PLUS Study)
Nathalie Costedoat-Chalumeau et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Baseline Predictors of Systemic Lupus Erythematosus Flares: Data From the Combined Placebo Groups in the Phase III Belimumab Trials
Michelle A. Petri et al.
ARTHRITIS AND RHEUMATISM (2013)
Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis
George K. Bertsias et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Anti-malarials exert a protective effect while Mestizo patients are at increased risk of developing SLE renal disease: data from a Latin-American cohort
Guillermo J. Pons-Estel et al.
RHEUMATOLOGY (2012)
American College of Rheumatology Guidelines for Screening, Treatment, and Management of Lupus Nephritis
Bevra H. Hahn et al.
ARTHRITIS CARE & RESEARCH (2012)
Outcomes in patients with systemic lupus erythematosus with and without a prolonged serologically active clinically quiescent period
Amanda J. Steiman et al.
ARTHRITIS CARE & RESEARCH (2012)
Antimalarial Treatment May Have a Time-Dependent Effect on Lupus Survival
Samuel K. Shinjo et al.
ARTHRITIS AND RHEUMATISM (2010)
Prolonged Serologically Active Clinically Quiescent Systemic Lupus Erythematosus: Frequency and Outcome
Amanda J. Steiman et al.
JOURNAL OF RHEUMATOLOGY (2010)
Prevalence of Flare and Influence of Demographic and Serologic Factors on Flare Risk in Systemic Lupus Erythematosus: A Prospective Study
Michelle Petri et al.
JOURNAL OF RHEUMATOLOGY (2009)
Low blood concentration of hydroxychloroquine is a marker for and predictor of disease exacerbations in patients with systemic lupus erythematosus
Nathalie Costedoat-Chalumeau et al.
ARTHRITIS AND RHEUMATISM (2006)
Therapy with pulse methylprednisolone and short course pulse cyclophosphamide for diffuse proliferative glomerulonephritis
M Mosca et al.
LUPUS (2001)
Hydroxychloroquine (HCQ) in lupus pregnancy: double-blind and placebo-controlled study
RA Levy et al.
LUPUS (2001)
分享论文
